FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved Actavis Pharma, Inc.'s supplemental application for CARTIA XT (diltiazem hydrochloride) under ANDA074752.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Atrial Fibrillation
• Atrial Flutter
• Hypertension
• Supraventricular Tachycardia

Drugs mentioned

• CARTIA XT (DILTIAZEM HYDROCHLORIDE)

Snippet

SUPPL AP for CARTIA XT (DILTIAZEM HYDROCHLORIDE)